Globally, drug regulators have approved statins for the prevention of cardiovascular disease (CVD), although their use in primary prevention has been controversial. A highly publicised debate has ...

Correspondence to Dr Elaine Lehane, Catherine McAuley School of Nursing and Midwifery, University College Cork, Cork T12 K8AF, Ireland; e.lehane{at}ucc.ie To highlight and advance clinical ...

Correspondence to Dr Franz Porzsolt, Health Care Research at the Dept General and Visceral Surgery, University Hospital Ulm, Ulm 89071, Germany; f.porzsolt{at}gmx.de The description of results in ...

Objectives To examine the association between regulatory reviewer disagreements and postmarket safety actions among novel therapeutics approved by the US Food and Drug Administration (FDA) between ...

1 NIHR ARC South West Peninsula, University of Exeter Medical School, University of Exeter, Exeter, UK 2 University of Exeter Medical School, University of Exeter, Exeter, UK Correspondence to Dr ...

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...

Correspondence to Professor John Brodersen, Centre of Research & Education in General Practice, Department of Public Health, University of Copenhagen, Faculty of Health Sciences, Copenhagen 1014, ...

Correspondence to Professor Friedemann Geiger, National Competency Center for Shared Decision Making, University Hospital Schleswig-Holstein, Kiel, Germany; f.geiger{at}uksh.de We developed The Six ...

Correspondence to Sir Iain Chalmers, James Lind Initiative, Summertown Pavilion, Middle Way, Oxford OX2 7LG, UK; ichalmers{at}jameslind.net We are surrounded by maelstroms of claims about the effects ...

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...